Effect of the Traditional Chinese Medicine Yufeng Ningxin in Patients With Hypertension

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 350 participants.

Also called NCT07607275

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 350 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07607275
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07607275. Randomized; quadruple masking; primary purpose treatment. Start 2026-05-15 (actual); primary completion 2027-12-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of the Traditional Chinese Medicine Yufeng Ningxin in Patients With Hypertension
Condition
Hypertension
Condition
Essential (Primary) Hypertension
Intervention (Drug)
Yufeng Ningxin tablets
Intervention (Drug)
Placebo
Lead sponsor
Beijing Anzhen Hospital (class: other)

Record details

Record id
cardio:ct-nct07607275
Content hash
9f2ca033942f83073ff7fea54aaa08632ba0884b08773eeee7b0969ee8d82759